Here is the link to the article. Symbicort will be gone from normal patent expiration in very early 2017. This will make it easier for generic competition to come in much faster. http://www.fiercepharma.com/story/bad-news-astrazeneca-fda-lays-out-roadmap-would-be-symbicort-copycats/2015-07-01?utm_medium=rss&utm_source=feedly&utm_campaign=rss